GEL imager for taking pictures of DNA gels. GEL electrophoresis is done abundantly in all of the labs in genotyping and cloning experiments.
Ended Awarded Last action
- Contract number
- 75N91020F00162
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,381
Award facts
- Contract value 100% obligated
- $11,380.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rodeo, CA 94547, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a firm fixed-price BPA call contract valued at $11,380.95 by the National Cancer Institute on July 13, 2020, for a gel imager system used to capture photographs of deoxyribonucleic acid (DNA) gels. Gel electrophoresis is a foundational laboratory technique widely employed across genotyping and cloning experiments throughout research facilities. This contract carries no small business set-aside designation and was completed by July 31, 2020. The equipment will be performed and delivered to Bio-Rad's headquarters location in Hercules, California.
This award represents a call against Bio-Rad's existing blanket purchase agreement framework with the National Institutes of Health, reflecting the company's established position as a critical supplier of advanced laboratory instrumentation to federal research agencies. Bio-Rad Laboratories, Inc. serves as a global leader in life science research and clinical diagnostics, with extensive experience providing sophisticated imaging systems, polymerase chain reaction equipment, and associated consumables to the National Cancer Institute, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Defense, among other agencies. The contract exemplifies the company's ongoing role in supporting molecular biology research capabilities across the federal government's scientific enterprise.
Quick answers
Who was awarded contract 75N91020F00162?
75N91020F00162 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on July 13, 2020.
How much is contract 75N91020F00162 worth?
The government has obligated $11,381 on 75N91020F00162.
Is contract 75N91020F00162 an order under another contract?
Yes. 75N91020F00162 is a BPA call under HHSN263201500172B, a blanket purchase agreement.
Was contract 75N91020F00162 competed?
The extent of competition for 75N91020F00162 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award